Literature DB >> 18574061

Leptin and cardiovascular disease: response to therapeutic interventions.

Kwang Kon Koh1, Sang Min Park, Michael J Quon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18574061      PMCID： PMC2746068          DOI： 10.1161/CIRCULATIONAHA.107.741645

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  118 in total

1.  Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.

Authors:  Atsushi Tsuchida; Toshimasa Yamauchi; Sato Takekawa; Yusuke Hada; Yusuke Ito; Toshiyuki Maki; Takashi Kadowaki
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy.

Authors:  Asad Zeidan; Daniel M Purdham; Venkatesh Rajapurohitam; Sabzali Javadov; Subrata Chakrabarti; Morris Karmazyn
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

3.  Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study.

Authors:  S Söderberg; P Zimmet; J Tuomilehto; P Chitson; H Gareeboo; K G M M Alberti; J E Shaw
Journal:  Int J Obes (Lond)       Date:  2007-02-27       Impact factor: 5.095

4.  Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway.

Authors:  Feng Dong; Xiaochun Zhang; Jun Ren
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

Review 5.  Role of leptin in blood pressure regulation and arterial hypertension.

Authors:  Jerzy Bełtowski
Journal:  J Hypertens       Date:  2006-05       Impact factor: 4.844

Review 6.  Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors:  Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Circulation       Date:  2006-04-18       Impact factor: 29.690

7.  Induction of leptin resistance through direct interaction of C-reactive protein with leptin.

Authors:  Ke Chen; Fanghong Li; Ji Li; Hongbo Cai; Steven Strom; Alessandro Bisello; David E Kelley; Miriam Friedman-Einat; Gregory A Skibinski; Mark A McCrory; Alexander J Szalai; Allan Z Zhao
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

8.  Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.

Authors:  Kwang Kon Koh; Michael J Quon; Yonghee Lee; Seung Hwan Han; Jeong Yeal Ahn; Wook-Jin Chung; Jeong-A Kim; Eak Kyun Shin
Journal:  Eur Heart J       Date:  2007-05-05       Impact factor: 29.983

9.  Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice.

Authors:  Tsuyoshi Chiba; Shohei Shinozaki; Toru Nakazawa; Akio Kawakami; Masumi Ai; Eiji Kaneko; Masanobu Kitagawa; Kazuo Kondo; Alan Chait; Kentaro Shimokado
Journal:  Atherosclerosis       Date:  2007-03-23       Impact factor: 5.162

Review 10.  Cardiovascular actions of insulin.

Authors:  Ranganath Muniyappa; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Endocr Rev       Date:  2007-05-24       Impact factor: 19.871
View more
  87 in total

1.  Adiponectin, leptin, and yoga practice.

Authors:  Janice K Kiecolt-Glaser; Lisa M Christian; Rebecca Andridge; Beom Seuk Hwang; William B Malarkey; Martha A Belury; Charles F Emery; Ronald Glaser
Journal:  Physiol Behav       Date:  2012-01-27

2.  Inflammation and hypertension in rheumatoid arthritis.

Authors:  Siriporn Manavathongchai; Aihua Bian; Young Hee Rho; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein
Journal:  J Rheumatol       Date:  2013-09-01       Impact factor: 4.666

Review 3.  Nutrigenetics-personalized nutrition in obesity and cardiovascular diseases.

Authors:  Luigi Barrea; Giuseppe Annunziata; Laura Bordoni; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

4.  Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?

Authors:  Meera Penumetcha; Nadya Merchant; Sampath Parthasarathy
Journal:  J Med Food       Date:  2010-12-27       Impact factor: 2.786

5.  Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.

Authors:  Kwang Kon Koh; Michael J Quon; Seung Hwan Han; Yonghee Lee; Soo Jin Kim; Yesl Koh; Eak Kyun Shin
Journal:  Int J Cardiol       Date:  2008-12-06       Impact factor: 4.164

6.  Race/Ethnicity-Specific Associations between Smoking, Serum Leptin, and Abdominal Fat: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Sina Kianoush; Andrew P DeFilippis; Carlos J Rodriguez; Mahmoud Al Rifai; Emelia J Benjamin; Michael E Hall; Pamela Ouyang; Matthew A Allison; Michael J Blaha
Journal:  Ethn Dis       Date:  2018-10-18       Impact factor: 1.847

Review 7.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

8.  Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.

Authors:  John Y Jun; Zhexi Ma; Rajkumar Pyla; Lakshman Segar
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

9.  Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.

Authors:  Carla R P Oliveira; Roberto Salvatori; Rafael A Meneguz-Moreno; Manuel H Aguiar-Oliveira; Rossana M C Pereira; Eugênia H A Valença; Vanessa P Araujo; Natália T Farias; Débora C R Silveira; Jose G H Vieira; Jose A S Barreto-Filho
Journal:  J Clin Endocrinol Metab       Date:  2009-12-16       Impact factor: 5.958

Review 10.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.